1. Home
  2. PTCT vs BCPC Comparison

PTCT vs BCPC Comparison

Compare PTCT & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$82.28

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$168.44

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
BCPC
Founded
1998
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.6B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
PTCT
BCPC
Price
$82.28
$168.44
Analyst Decision
Buy
Buy
Analyst Count
17
2
Target Price
$80.65
$176.00
AVG Volume (30 Days)
2.2M
211.0K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
0.55%
EPS Growth
264.48
20.87
EPS
N/A
1.25
Revenue
$264,734,000.00
$799,023,000.00
Revenue This Year
N/A
$8.47
Revenue Next Year
$17.70
$4.89
P/E Ratio
N/A
$135.04
Revenue Growth
36.19
13.56
52 Week Low
$43.18
$139.17
52 Week High
$87.50
$183.90

Technical Indicators

Market Signals
Indicator
PTCT
BCPC
Relative Strength Index (RSI) 65.15 61.58
Support Level $73.41 $167.19
Resistance Level $87.27 $169.74
Average True Range (ATR) 3.11 3.55
MACD 0.22 0.50
Stochastic Oscillator 75.57 55.92

Price Performance

Historical Comparison
PTCT
BCPC

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: